These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 3048080)

  • 21. Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use.
    Larkai EN; Smith JL; Lidsky MD; Graham DY
    Am J Gastroenterol; 1987 Nov; 82(11):1153-8. PubMed ID: 3499815
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta.
    Hogan DB; Campbell NR; Crutcher R; Jennett P; MacLeod N
    CMAJ; 1994 Aug; 151(3):315-22. PubMed ID: 8039085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.
    Tannenbaum H; Davis P; Russell AS; Atkinson MH; Maksymowych W; Huang SH; Bell M; Hawker GA; Juby A; Vanner S; Sibley J
    CMAJ; 1996 Jul; 155(1):77-88. PubMed ID: 8673987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gastrointestinal side-effects of traditional non-steroidal anti-inflammatory drugs and new formulations.
    Lazzaroni M; Bianchi Porro G
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 2():48-58. PubMed ID: 15335413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NSAID-induced gastrointestinal damage: current clinical management and recommendations for prevention.
    Lanas A; Ferrandez A
    Chin J Dig Dis; 2006; 7(3):127-33. PubMed ID: 16808792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prevention and treatment of non-steroidal anti-inflammatory drug gastroenteropathy].
    Lanas A
    Rev Gastroenterol Mex; 2004; 69(4):251-60. PubMed ID: 15765979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of nonsteroidal anti-inflammatory drugs on endogenous gastrointestinal prostaglandins and therapeutic strategies for prevention and treatment of nonsteroidal anti-inflammatory drug-induced damage.
    Cryer B; Feldman M
    Arch Intern Med; 1992 Jun; 152(6):1145-55. PubMed ID: 1599341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological aspects of NSAID gastropathy.
    Guslandi M
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():6-8. PubMed ID: 9032573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract].
    Bures J; Rejchrt S; Kopácová M; Siroký M
    Cas Lek Cesk; 2002 Oct; 141(21):673-9. PubMed ID: 12564374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striking prevalence of over-the-counter nonsteroidal anti-inflammatory drug use in patients with upper gastrointestinal hemorrhage.
    Wilcox CM; Shalek KA; Cotsonis G
    Arch Intern Med; 1994 Jan; 154(1):42-6. PubMed ID: 8267488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NSAID, ulcers, and prostaglandins.
    Kimmey MB
    J Rheumatol Suppl; 1992 Nov; 36():68-73. PubMed ID: 1474538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upper gastrointestinal lesions in elderly patients presenting for endoscopy: relevance of NSAID usage.
    Bellary SV; Isaacs PE; Lee FI
    Am J Gastroenterol; 1991 Aug; 86(8):961-4. PubMed ID: 1858761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Digestive complications of non-steroidal anti-inflammatory drugs].
    Colin R
    Schweiz Med Wochenschr; 1991 May; 121(20):716-21. PubMed ID: 2057738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment and prevention of nonsteroidal anti-inflammatory drug induced gastrointestinal mucosal injury.
    Agrawal NM; Dajani EZ
    Int J Clin Pharmacol Res; 1989; 9(6):347-57. PubMed ID: 2576801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pathologic condition and prognosis of NSAids ulcer].
    Nishimura S; Uemura N
    Nihon Rinsho; 2011 Jun; 69(6):1003-6. PubMed ID: 21688619
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prophylaxis and treatment of NSAID-related peptic ulceration: present status and prospects].
    Hiraishi H; Akima T; Sugaya T; Nakano M; Nomura M
    Nihon Rinsho; 2011 Jun; 69(6):988-94. PubMed ID: 21688617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic imaging of NSAID ulcers].
    Ono S; Kato M; Asaka M; Ono Y; Yokoyama A
    Nihon Rinsho; 2007 Oct; 65(10):1792-800. PubMed ID: 17926526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.